DRN:ARCA-Dexion Daily Real Estate Bull 3x Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 8.45

Change

+0.07 (+0.84)%

Market Cap

USD 0.07B

Volume

1.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the MSCI US REIT IndexSM. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the MSCI US REIT IndexSM and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is a free float-adjusted market capitalization weighted index that is comprised of equity REITs that are included in the MSCI US Investable Market 2500 Index. The fund is non-diversified.

Inception Date: 16/07/2009

Primary Benchmark: MSCI US IMI/Real Estate 25-50 GR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.96%

Management Expense Ratio: 1.09 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-13 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 10.44B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 6.32B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 5.10B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 4.82B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

N/A

USD 4.46B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 3.36B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.07B
FAS Direxion Daily Financial Bull .. 1.04 %

N/A

USD 2.09B
TNA Direxion Daily Small Cap Bull .. 1.10 %

N/A

USD 1.92B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 1.10B

ETFs Containing DRN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.43% 6% D- 7% C-
Dividend Return 0.39% 72% C 21% F
Total Return -20.04% 6% D- 7% C-
Trailing 12 Months  
Capital Gain -7.04% 12% F 18% F
Dividend Return 2.74% 87% B+ 40% F
Total Return -4.30% 12% F 18% F
Trailing 5 Years  
Capital Gain -67.26% 12% F 6% D-
Dividend Return 8.44% 87% B+ 29% F
Total Return -58.82% 13% F 7% C-
Average Annual (5 Year Horizon)  
Capital Gain -1.36% 19% F 33% F
Dividend Return 1.37% 25% F 33% F
Total Return 2.74% 90% A- 57% F
Risk Return Profile  
Volatility (Standard Deviation) 72.99% 51% F 11% F
Risk Adjusted Return 1.88% 25% F 28% F
Market Capitalization 0.07B 45% F 21% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.